Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation

Area of Science:

• Genetics
• Immunology
• Neuroscience

Background:

• Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
• The genetic architecture of MS susceptibility is complex, involving numerous genetic loci.
• Genome-wide association studies (GWAS) are powerful tools for identifying genetic variants associated with complex diseases.

Purpose of the Study:

• To identify novel genetic loci associated with multiple sclerosis susceptibility using a GWAS approach.
• To investigate the role of identified genes in immune cell regulation and epigenetic processes relevant to MS pathogenesis.

Main Methods:

• Conducted a GWAS in German cohorts comprising 4888 MS cases and 10,395 controls.
• Analyzed associations within and outside the major histocompatibility complex (MHC) region.
• Replicated novel findings in an independent Sardinian cohort.

Main Results:

• Identified 15 non-MHC loci associated with genome-wide significance for MS susceptibility.
• Discovered four novel MS susceptibility loci mapping to L3MBTL3, MAZ, ERG, and SHMT1.
• Confirmed the lead variant at SHMT1 in a Sardinian cohort; L3MBTL3, MAZ, and ERG products are implicated in immune regulation, while SHMT1 is crucial for methylation homeostasis.

Conclusions:

• The study identified novel genetic risk factors for multiple sclerosis, expanding the known genetic landscape of the disease.
• The identified genes, particularly SHMT1, highlight the importance of epigenetic regulation and folate metabolism in MS pathogenesis.
• The GWAS approach in a genetically defined population successfully detected associations missed in more heterogeneous cohorts, offering new insights into MS etiology.